Allay Therapeutics

Allay Therapeutics

  • Founded: 2017
  • Location: Menlo Park, CA
  • Employee range: 11 - 50
  • Clinical stage: Clin2
  • Therapy area: Knee replacement surgery pain
  • Drug types: PN, ANE
  • Lead product: ATX-101
  • Product link:
  • Funding: $60M C Sep 2021

job board

Short description:

Multi-week Localized Pain Management

Drug notes:

ATX-201 Clin0 pain; ATX-301 Clin0 pain; ATX-401 Clin0 pain; ATX-501 RD/Clin0 anesthesia

Long description:

Allay Therapeutics is pioneering products to help patients recover from post-surgical pain management. Current pain management products provide several days of pain relief, much shorter than the weeks or months of post-surgical recuperation that millions of patients cope with. To resolve this, Allay has developed the first technology designed to deliver weeks of localized pain management. Allay’s proprietary technology combines validated non-opioid analgesics and biopolymers to create candidates that deliver targeted pain relief. By tuning the drug-biopolymer architecture that alters the analgesic release profile, Allay can design their technology for a variety of potential applications. Allay’s lead candidate, ATX-101, is designed to support recuperation from total knee-replacement surgery.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy